EP2331084A4 - Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereof - Google Patents
Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereofInfo
- Publication number
- EP2331084A4 EP2331084A4 EP09818889.9A EP09818889A EP2331084A4 EP 2331084 A4 EP2331084 A4 EP 2331084A4 EP 09818889 A EP09818889 A EP 09818889A EP 2331084 A4 EP2331084 A4 EP 2331084A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pharmaceutical compositions
- dosage forms
- amorphous esomeprazole
- esomeprazole
- amorphous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2315DE2008 | 2008-10-06 | ||
PCT/IN2009/000553 WO2010041276A1 (en) | 2008-10-06 | 2009-10-06 | Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2331084A1 EP2331084A1 (en) | 2011-06-15 |
EP2331084A4 true EP2331084A4 (en) | 2014-01-22 |
Family
ID=42100256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09818889.9A Withdrawn EP2331084A4 (en) | 2008-10-06 | 2009-10-06 | Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereof |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2331084A4 (en) |
WO (1) | WO2010041276A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011140446A2 (en) * | 2010-05-06 | 2011-11-10 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical formulations |
WO2011154009A1 (en) * | 2010-06-10 | 2011-12-15 | Lifecycle Pharma A/S | Composition comprising an active principle in an amorphous form and a porous adsorbent material |
IT1401284B1 (en) * | 2010-08-06 | 2013-07-18 | Valpharma S P A | NEW PHARMACEUTICAL FORMULATIONS SUITABLE FOR ORAL ADMINISTRATION OF DIHYDRATE ESOMEPRAZOLE MAGNESIUM, IN THE FORM OF MUPS TABLETS (MULTI UNIT PELLETS SYSTEM). |
EP2604256B1 (en) * | 2011-12-14 | 2016-04-13 | Hexal AG | Multi layer coatings |
CN103462924A (en) * | 2012-06-06 | 2013-12-25 | 南京亿华药业有限公司 | Prescription and preparation method of esomeprazole sustained release tablet |
CN103520226B (en) * | 2013-10-11 | 2015-09-02 | 惠州市九惠制药股份有限公司 | A kind of pH dependent form conlon targeting hard capsule |
EP3292862A1 (en) * | 2016-09-07 | 2018-03-14 | Sandoz Ag | Omeprazole formulations |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1801110A1 (en) * | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1964704A (en) * | 2004-03-03 | 2007-05-16 | 特瓦制药工业有限公司 | Stable pharmaceutical composition comprising an acid labile drug |
AR057181A1 (en) * | 2005-11-30 | 2007-11-21 | Astra Ab | NEW COMBINATION DOSAGE FORM |
EP1813275A1 (en) * | 2005-12-20 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | Lansoprazole orally disintegrating tablets |
TR201816133T4 (en) * | 2006-04-04 | 2018-11-21 | Kg Acquisition Llc | ORAL DOSAGE FORMS WITH AN ANTIPLATELET AGENT AND AN ACID INHIBITOR. |
WO2008018825A1 (en) * | 2006-08-10 | 2008-02-14 | Astrazeneca Ab | Oral polyvinyl alcohol capsules comprising proton pump inhibitors |
-
2009
- 2009-10-06 EP EP09818889.9A patent/EP2331084A4/en not_active Withdrawn
- 2009-10-06 WO PCT/IN2009/000553 patent/WO2010041276A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1801110A1 (en) * | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
Non-Patent Citations (1)
Title |
---|
See also references of WO2010041276A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2331084A1 (en) | 2011-06-15 |
WO2010041276A1 (en) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275854A (en) | Pharmaceutical composition and administration thereof | |
IL271132A (en) | Novel dosage and formulation | |
IL225637A0 (en) | Formulations, tablets comprising such formulations their use and process for their preparation | |
AP3438A (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof | |
ZA201006029B (en) | Pharmaceutical dosage form | |
IL206288A0 (en) | Novel dosage and formulation | |
ZA201005015B (en) | Solid pharmaceutical dosage form | |
IL207569A0 (en) | Compositions and methods for drug delivery | |
IL211314A (en) | Pharmaceutical dosage forms comprising poly (epsilon-caprolactone) | |
EP2144601A4 (en) | Rapidly dissolving pharmaceutical compositions comprising pullulan | |
EP2379079A4 (en) | Pharmaceutical formulations comprising voriconazole and processes for preparation thereof | |
IL211018A (en) | Inhibitors, processes for their preparation, pharmaceutical compositions comprising them and their use | |
EP2205218A4 (en) | Pharmaceutical composition containing esomeprazole | |
IL195764A0 (en) | Compositions and methods for drug delivery | |
IL217927A (en) | Azaheterocyclic compounds and pharmaceutical compositions and set comprising them | |
ZA200903858B (en) | Pharmaceutical dosage form | |
EP2251006A4 (en) | Microparticles and pharmaceutical compositions thereof | |
IL213452A0 (en) | Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | |
EP2331084A4 (en) | Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereof | |
IL217053A0 (en) | Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
EP2284158A4 (en) | Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof | |
EP2306998A4 (en) | Pharmaceutical formulation | |
IL212171A (en) | 1-phenylpyrrole compounds, pharmaceutical compositions comprising them and their uses | |
IL207200A0 (en) | Imidiazopyridazines as par1 inhibitors, production thereof,and use thereof as medicaments | |
IL218726A0 (en) | Methods and pharmaceutical compositions for treating down syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110328 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20140103 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/4439 20060101ALI20131218BHEP Ipc: A61K 9/54 20060101AFI20131218BHEP Ipc: A61K 33/06 20060101ALI20131218BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20150109 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20150520 |